Alembic Pharmaceuticals has reported results for first quarter ended June 30, 2015.
The company has reported 24.11% rise in its net profit at Rs 76.30 crore for the quarter ended June 30, 2015 as compared to Rs 61.48 crore for the same quarter in the previous year. The company’s total income has increased by 19.28% to Rs 574.89 crore for the quarter under review from Rs 481.98 crore for the corresponding quarter of the previous year.
On the consolidated basis, the company has reported 8.06% rise in its net profit after taxes, minority interest and share of profit /(Loss) of associates of Rs 69.88 crore for the quarter ended June 30, 2015 as compared to Rs 64.67 crore for the same quarter in the previous year. Total income of the company has increased by 17.98% at Rs 583.37 crore for quarter under review as compared to Rs 494.46 crore for the quarter ended June 30, 2014.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1808.50 |
Dr. Reddys Lab | 1342.45 |
Cipla | 1472.45 |
Lupin | 2147.55 |
Zydus Lifesciences | 973.90 |
View more.. |